Glaucoma Research Foundation

May is Healthy Vision Month

Wed, 01 May 2013 15:20:19 -0800

Glaucoma Research Foundation joins the National Eye Institute in celebrating Healthy Vision Month each May to promote eye health as a priority for the nation.

Alternative Therapies for Glaucoma

Wed, 01 May 2013 13:55:20 -0800

It is estimated that 5-15% of glaucoma patients, reportedly spending billions of dollars annually, take some form of alternative medication based only on their impression that it will help treat their glaucoma.

Exfoliative Glaucoma

Wed, 01 May 2013 12:04:33 -0800

Glaucoma develops in some patients with a condition called exfoliation syndrome. Also known as pseudoexfoliation, it is caused by the abnormal accumulation of protein in the drainage system and other structures of the eye.

The Biomarker Initiative: 2013 Progress Report

Wed, 01 May 2013 11:26:26 -0800

How can we better diagnose or track the progression of glaucoma? The discovery of improved biomarkers for early detection or disease progression has the potential to radically change treatment of glaucoma.

2013 Research Grants

Wed, 01 May 2013 09:11:06 -0800

Glaucoma Research Foundation provides seed money for creative pilot research projects that hold promise. We consider it vital to invest funds in new high-impact research that may lead to major government and philanthropic support.

New Web Site Helps Patients Have a Bigger Voice at FDA

Tue, 23 Apr 2013 11:12:16 -0800

FDA’s Patient Network supports people who are looking for reliable information about medical products and their approvals, clinical trials, and other treatment options.

Glaucoma Facts and Stats

Mon, 22 Apr 2013 03:35:00 -0800

Glaucoma is a very misunderstood disease. Often, people don't realize the severity or who is affected.

Catalyst for a Cure: Neuroprotection

Mon, 08 Apr 2013 16:33:29 -0800

Launched in 2002, the original team of four Catalyst for a Cure investigators has made a significant impact on the field of glaucoma research, helping to redefine our understanding of how glaucoma steals sight

On National Doctors' Day, Eye Doctors Urge Eye Health Awareness

Fri, 29 Mar 2013 09:42:49 -0800

Vision is our most prized sense, but to maintain healthy vision, we need to care for our eyes and have regular checkups.

New Resources Help Growing Number of Americans with Vision Loss

Fri, 22 Mar 2013 10:56:09 -0800

A 20-page large-print booklet and a series of videos to help people adapt to life with low vision are available from the National Eye Institute (NEI), a part of the National Institutes of Health.

Dr. Gareth Howell Receives Shaffer Prize for Innovative Research

Thu, 21 Mar 2013 16:10:55 -0800

Dr. Gareth Howell was awarded the 2013 Shaffer Prize for Innovative Glaucoma Research for his study investigating the mechanism by which a spontaneous mutation prevents retinal ganglion cell death in glaucoma.

Catalyst Researcher David Calkins Receives Senior Scientific Investigator Award

Thu, 21 Mar 2013 12:04:55 -0800

David Calkins, PhD, Catalyst for a Cure investigator and Vice Chair and Director of Research for the Vanderbilt Eye Institute, was recently awarded a Research to Prevent Blindness Senior Scientific Investigator Award.

Catalyst for a Cure: A Decade of Innovation

Mon, 18 Mar 2013 15:40:07 -0800

Catalyst for a Cure is a unique approach to research developed by Glaucoma Research Foundation, which brings together scientists from different backgrounds to work collaboratively to understand glaucoma with the goal of finding a cure.

Second Catalyst Research Team Sets Sights on Biomarker Discovery

Mon, 18 Mar 2013 15:13:03 -0800

Glaucoma Research Foundation has expanded its novel initiative to advance glaucoma research through a collaborative approach by bringing together a new Catalyst for a Cure research team.

Original CFC Investigators Continue on Path of Discovery, Innovation

Mon, 18 Mar 2013 14:52:49 -0800

The first Catalyst for a Cure research team has worked together for 11 years to elucidate the molecular mechanisms of neurodegeneration in glaucoma and new therapeutic targets.